April 10 (Reuters) - CERo Therapeutics Holdings Inc CERO.O:
CERO THERAPEUTICS HOLDINGS, INC. ANNOUNCES CRITICAL PATENT APPLICATION ALLOWANCES FROM THE U.S. PATENT OFFICE COVERING COMPANY’S LEAD COMPOUND CER-1236
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.